Zoliflodacin clinical trials
Also written AZD0914.
How each study uses zoliflodacin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the zoliflodacin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 12 Dec 2025 · NUZOLVENCE · NDA 219491 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
8 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 7
Global Antibiotics Research and Development Partnership (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Drugs for Neglected Diseases (1) · Entasis Therapeutics (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test zoliflodacin.
- Jun 2027Pharmacokinetics of Oral Zoliflodacin 3 g in Healthy Lactating WomenPhase 4 · Global Antibiotics Research and Development Partnership
- Nov 2027Study to Evaluate the Effect of Zoliflodacin on Testicular Function in Healthy Adult MenPhase 4 · Global Antibiotics Research and Development Partnership
Studies
Open first, then newest update. How each study uses zoliflodacin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Study to Evaluate the Effect of Zoliflodacin on Testicular Function in Healthy Adult MenNot yet recruitingPhase 4Global Antibiotics Research and Development PartnershipNCT07640477Written as Zoliflodacin
- Pharmacokinetics of Oral Zoliflodacin 3 g in Healthy Lactating WomenNot yet recruitingPhase 4Global Antibiotics Research and Development PartnershipNCT07926997Written as Zoliflodacin
- Zoliflodacin in Uncomplicated GonorrhoeaCompletedPhase 3Global Antibiotics Research and Development PartnershipNCT03959527Written as zoliflodacin
- Thorough QT/QTC (TQT) Clinical Trial to Evaluate the Effect of Zoliflodacin on Cardiac Repolarization in Healthy Male and Female SubjectsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT03613649Written as AZD0914
- A Study to Evaluate the Safety, Tolerability and Plasma PK of a Single Oral Dose of Zoliflodacin in Healthy Male and Female VolunteersCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT03404167Written as AZD0914
- Study to Investigate Effect of Food and Safety of a New Formulation of ZoliflodacinCompletedPhase 1Drugs for Neglected DiseasesNCT03718806Written as Zoliflodacin
- Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of GonorrheaCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT02257918Written as AZD0914
- AZD0914 Phase 1 ADME Study in Healthy VolunteersCompletedPhase 1Entasis TherapeuticsNCT02298920Written as AZD0914
Codes
What other systems call zoliflodacin · ClinicalTrials.gg INT000256
- MeSH (NLM) C000599190zoliflodacinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) FWL2263R77ZOLIFLODACINConfirmed FDA, NLM, Wikidata
- Wikidata Q27278240zoliflodacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152962ZoliflodacinOne source FDA
- DrugBank DB12817One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000599190 | zoliflodacin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | FWL2263R77 | ZOLIFLODACIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27278240 | zoliflodacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152962 | Zoliflodacin | One source FDA |
| DrugBank | DB12817 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.